Filing Flows › P3 Health Partners (PIII) › Who owns the stock
Who owns P3 Health Partners (PIII) stock
17 funds reported P3 Health Partners (PIII) shares in their latest 13F filings, worth $2.5M in all. The largest holder is Jane Street Group, LLC ($589K). Last quarter 9 funds added to their stakes and 9 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Jane Street Group, LLC | 54,495 | $589K | new | 2026-06-30 |
| Vanguard Capital Management LLC | 41,484 | $448K | decrease | 2026-06-30 |
| Myda Advisors LLC | 20,000 | $216K | new | 2026-06-30 |
| Corient Private Wealth LLC | 19,737 | $213K | decrease | 2026-06-30 |
| Geode Capital Management, LLC | 17,096 | $185K | decrease | 2026-06-30 |
| Scientech Research LLC | 16,318 | $176K | new | 2026-06-30 |
| Vanguard Group | 48,117 | $168K | decrease | 2025-12-31 |
| Renaissance Technologies LLC | 15,149 | $164K | new | 2026-06-30 |
| Diversified Trust | 13,440 | $145K | decrease | 2026-06-30 |
| BlackRock | 7,637 | $82K | decrease | 2026-06-30 |
| Vanguard Fiduciary Trust | 6,477 | $70K | unchanged | 2026-06-30 |
| Morgan Stanley | 2,820 | $30K | new | 2026-06-30 |
| UBS Group AG | 2,328 | $25K | increase | 2026-06-30 |
| Tower Research Capital LLC | 540 | $6K | new | 2026-06-30 |
| Vanguard Global Advisers, LLC | 308 | $3K | unchanged | 2026-06-30 |
P3 Health Partners' latest quarter
P3 Health Partners, Q2 2026: revenue $386M (+9% year over year), operating margin 10.7%, net earnings $7.4M, operating cash flow −$61.9M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most PIII stock?
By the latest 13F filings: Jane Street Group, LLC ($589K); Vanguard Capital Management LLC ($448K); Myda Advisors LLC ($216K); Corient Private Wealth LLC ($213K); Geode Capital Management, LLC ($185K).
What is the short interest in PIII?
11,325 shares were sold short at the 2026-10-15 settlement, -16.95% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.